III.J.32. Biological Warfare Agent Confirmation Diagnostic Kit. Description: Develop the capability to confirm the initial field diagnosis obtained with the forward deployable diagnostic kit. These tests will differ from forward deployed tests by being more specific, more sensitive, and using independent biological markers. By FY98, transition to development confirmation techniques for all biological warfare (BW) agents in the theater of operations.
Supports: DEPSECDEF guidance (26 AUG 91); Joint Requirements Oversight Council guidance (31 AUG 92); Combat Service Support and Dismounted Battle Labs.
|STO Manager:||TSO:||TRADOC POC:|
|Dr. Anna Johnson-Winegar||MAJ Mark Seymour||CPT Ensor|